CELLINK launches BioVerse - a platform for 3D-Bioprinting

The launch of BioVerse (www.bioverse.co) is a revolutionary step for the entire bioprinting community and one that many have been waiting for

The community is a cloud based platform that connects researchers, scientists, and even doctors from all over the world and provide them with a space where they can innovate together and take the field of Bioprinting and 3D-Printing in medicine to the next level. The BioVerse platform is designed to allow users to upload 3D-models and download models, share protocols to assist with the bioprinting process, and even discuss innovative ideas and brain storm in the forum. BioVerse is the natural platform to meet and evolve the field of 3D-Bioprinting.

For additional information please contact:

Erik Gatenholm, VD                                          Gusten Danielsson, CFO
Phone: +46 73 267 00 00                                Phone: +46 70 991 86 04
E-mail: eg@cellink.com                                   E-mail: gd@cellink.com

About CELLINK

CELLINK has created one of the world's first universal bioink currently used by many of the world's most renowned research institutions. A bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in 3D-Bioprinters. CELLINKs’ universal bioink show excellent results and can be used in both CELLINKs’ 3D-Bioprinter as in other 3D-Bioprinters developed by other operators. Mangold Fondkomission AB, tel: +46 8 5030 1550, is CELLINKs’ Certified Adviser.